• Vector (a quantity possessing both magnitude and direction, represented by an arrow the direction of which indicates the direction of the quantity and the length of which is proportional to the magnitude; such a quantity with the additional requirement that such quantities are to transform in a particular way under changes of the coordinate system). • Vectory (a Scandinavian company specialised in solutions incorporating inertial sensors). • Verticality (position at right angles to the horizon).
{"title":"Vector(y) & Verticality for Victory -the Form of Good Health","authors":"","doi":"10.33140/jcei.05.05.05","DOIUrl":"https://doi.org/10.33140/jcei.05.05.05","url":null,"abstract":"• Vector (a quantity possessing both magnitude and direction, represented by an arrow the direction of which indicates the direction of the quantity and the length of which is proportional to the magnitude; such a quantity with the additional requirement that such quantities are to transform in a particular way under changes of the coordinate system). • Vectory (a Scandinavian company specialised in solutions incorporating inertial sensors). • Verticality (position at right angles to the horizon).","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"124 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75498544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Each year approximately 60,000 people die from hemorrhagic shock in the U.S.A. with about two million deaths worldwide [1]. Deaths from traumatic shock, worldwide, has been difficult to estimate, due to battles/wars in many countries, but is thought to be more than two million victims/year [1]. Many reasons for these large numbers of deaths are known [for review, see1], for example, inadequate therapeutic measures, unavailability of adequate blood/ plasma/fluid replacement, seeing the patient too late, and unavailability of trained ER personnel, among the major reasons [for recent review, see1]. Another predominant reason for large numbers of hemorrhagic and traumatic shock deaths is the risk of sepsis in many of these victims, resulting in septic shock having mortalities in excess of 40- 75%, depending upon locality, with the lower numbers in the U.S.A. Lastly, and most important is “natural resistance of the body to infectious microorganisms” (i.e, bacteria, funguses, viruses, parasitic organisms, etc.). What is responsible for “natural resistance” has been studied for more than 150 years. We know that the “innate” and “adaptive” immune systems are key elements in defense against infectious microorganisms [2, 3]. But, which elements of these systems make-up major aspects of “resistance” and “host defense” still remains to be worked out. Using starfish, more than 140 years ago, the pioneer/father of immunology, and Nobel Laureate, Elie Metchnikoff, believed that white blood cells and macrophages were key to host-defense [4]. He also believed the body develops molecules/substances, which are key to resistance to infectious microorganisms [4].
{"title":"HDFx and Methylated DNA; With Histones Upregulated in Macrophages/\u0000Monocytes Derived From Animal Survivors Subjected to Traumatic, Endotoxin,\u0000and Hemorrhagic Shock: Importance of Epigenesis and Potential Reasons for\u0000Resistance to Bacterial, Fungal and Viral Infections","authors":"","doi":"10.33140/jcei.05.04.07","DOIUrl":"https://doi.org/10.33140/jcei.05.04.07","url":null,"abstract":"Each year approximately 60,000 people die from hemorrhagic\u0000shock in the U.S.A. with about two million deaths worldwide [1].\u0000Deaths from traumatic shock, worldwide, has been difficult to\u0000estimate, due to battles/wars in many countries, but is thought to\u0000be more than two million victims/year [1]. Many reasons for these\u0000large numbers of deaths are known [for review, see1], for example,\u0000inadequate therapeutic measures, unavailability of adequate blood/\u0000plasma/fluid replacement, seeing the patient too late, and\u0000unavailability of trained ER personnel, among the major reasons\u0000[for recent review, see1]. Another predominant reason for large\u0000numbers of hemorrhagic and traumatic shock deaths is the risk of\u0000sepsis in many of these victims, resulting in septic shock having\u0000mortalities in excess of 40- 75%, depending upon locality, with the\u0000lower numbers in the U.S.A. Lastly, and most important is “natural\u0000resistance of the body to infectious microorganisms” (i.e, bacteria,\u0000funguses, viruses, parasitic organisms, etc.). What is responsible\u0000for “natural resistance” has been studied for more than 150 years.\u0000We know that the “innate” and “adaptive” immune systems are\u0000key elements in defense against infectious microorganisms [2, 3].\u0000But, which elements of these systems make-up major aspects of\u0000“resistance” and “host defense” still remains to be worked out.\u0000Using starfish, more than 140 years ago, the pioneer/father of\u0000immunology, and Nobel Laureate, Elie Metchnikoff, believed that\u0000white blood cells and macrophages were key to host-defense [4].\u0000He also believed the body develops molecules/substances, which\u0000are key to resistance to infectious microorganisms [4].","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91392936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This article is based on the continuation of the author’s research work, a simple and practical, yet highly accurate postprandial plasma glucose (PPG) prediction formula for type 2 diabetes (T2D) patients. His methodology is the developed GH-Method: math-physical medicine (MPM) which has been utilized repeatedly in the past decade. The predicted PPG formula-based on the status of fasting plasma glucose (FPG), carbs/sugar intake amount, and postmeal walking steps are as follows: Predicted PPG = 0.97 * FPG + (carbs/sugar grams * 1.8) - (post-meal walking steps in thousand * 5) The conclusive results have the order of values m1 / m2 /m3 / prediction accuracy %. Case A: 1.8 / 5.0 / 0.97 / 99.8% Case B: 2.0 / 5.0 / 0.945 / 99.9% Case C: 2.2 / 5.0 / 0.92 / 99.9% Exercise is important, contributing ~3% higher than food, is easily achieved compared to the required knowledge of diet. As a result, the author spent four years to study food nutrition. Most T2D patients are seniors; therefore, he suggests that walking is the best form of exercise. However, the most difficult part of exercise is the behavior psychology related to the issue of “discipline and persistence”. T2D patients need to walk between 2,000 to 4,000 steps after each meal. The author walks an average of 4,300 steps after each meal. On the other hand, diet (carbs/sugar amount and nutritional balance) requires much more and deeper knowledge of food nutrition in order to control diabetes. Therefore, the author developed an AI-based tool to assist T2D patients. For non-tech patients, the following simple guidelines can assist with meal intake: Starchy food: Eat an amount half of your fist or hand at most Colorful vegetables: Eat an amount limited to one fist or hand. Green vegetables: Eat an amount limited to 2.5 fists or hands. Please note: you must combine two types of vegetable together in order to get the total intake limitation. The author highly recommends the patients to measure their FPG at least several times a quarter, in order to get a quarterly average FPG value. The other three PPG values can then utilize the formula-based predicted PPG to control their overall diabetes conditions. The described method mentioned above in regard to the predicted PPG formula along with the post-meal walking exercise and carbs/sugar intake amount can help patients control their diabetes without painful and troublesome fingerpiercing glucose measurements. The author has been measuring his glucoses for 8.5 years (3,126 days) with fingerpiercing glucose testing combined with his 10-years of diabetes research work. He hopes this article can provide useful guidelines to other diabetes patients to take back their lives from this dreadful chronic disease.
{"title":"A simple formula based on postprandial plasma glucose prediction using 5,640\u0000meals data via GH-Method: math-physical medicine (No. 301)","authors":"","doi":"10.33140/jcei.05.05.004","DOIUrl":"https://doi.org/10.33140/jcei.05.05.004","url":null,"abstract":"This article is based on the continuation of the author’s research work, a simple and practical, yet highly accurate\u0000postprandial plasma glucose (PPG) prediction formula for type 2 diabetes (T2D) patients. His methodology is the\u0000developed GH-Method: math-physical medicine (MPM) which has been utilized repeatedly in the past decade.\u0000The predicted PPG formula-based on the status of fasting plasma glucose (FPG), carbs/sugar intake amount, and postmeal walking steps are as follows:\u0000Predicted PPG\u0000= 0.97 * FPG + (carbs/sugar grams * 1.8) - (post-meal walking steps in thousand * 5)\u0000The conclusive results have the order of values m1 / m2 /m3 / prediction accuracy %.\u0000Case A: 1.8 / 5.0 / 0.97 / 99.8%\u0000Case B: 2.0 / 5.0 / 0.945 / 99.9%\u0000Case C: 2.2 / 5.0 / 0.92 / 99.9%\u0000Exercise is important, contributing ~3% higher than food, is easily achieved compared to the required knowledge of\u0000diet. As a result, the author spent four years to study food nutrition. Most T2D patients are seniors; therefore, he\u0000suggests that walking is the best form of exercise. However, the most difficult part of exercise is the behavior psychology\u0000related to the issue of “discipline and persistence”. T2D patients need to walk between 2,000 to 4,000 steps after each\u0000meal. The author walks an average of 4,300 steps after each meal. On the other hand, diet (carbs/sugar amount and\u0000nutritional balance) requires much more and deeper knowledge of food nutrition in order to control diabetes. Therefore,\u0000the author developed an AI-based tool to assist T2D patients.\u0000For non-tech patients, the following simple guidelines can assist with meal intake:\u0000Starchy food:\u0000Eat an amount half of your fist or hand at most\u0000Colorful vegetables:\u0000Eat an amount limited to one fist or hand.\u0000Green vegetables:\u0000Eat an amount limited to 2.5 fists or hands.\u0000Please note: you must combine two types of vegetable together in order to get the total intake limitation.\u0000The author highly recommends the patients to measure their FPG at least several times a quarter, in order to get a\u0000quarterly average FPG value. The other three PPG values can then utilize the formula-based predicted PPG to control\u0000their overall diabetes conditions.\u0000The described method mentioned above in regard to the predicted PPG formula along with the post-meal walking\u0000exercise and carbs/sugar intake amount can help patients control their diabetes without painful and troublesome fingerpiercing glucose measurements. The author has been measuring his glucoses for 8.5 years (3,126 days) with fingerpiercing glucose testing combined with his 10-years of diabetes research work. He hopes this article can provide useful\u0000guidelines to other diabetes patients to take back their lives from this dreadful chronic disease.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90962600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In this case study, the author analyzed, predicted, and interpreted a type 2 diabetes (T2D) patient’s hemoglobin A1C variances based on six periods data utilizing the GH-Method: math-physical medicine approach by applying mathematics, physics, engineering modeling, and computer science (big data analytics and AI). He believes in “prediction” and has developed five models, including metabolism index, weight, fasting plasma glucose (FPG), postprandial plasma glucose (PPG), and hemoglobin A1C. All prediction models have reached to 95% to 99% accuracy. His focus is on preventive medicine, especially on diabetes control via lifestyle management.
{"title":"A1C Variance Study and PPG Prediction Methodology over Six Periods Using GH-Method: Math-Physical Medicine","authors":"","doi":"10.33140/jcei.05.04.01","DOIUrl":"https://doi.org/10.33140/jcei.05.04.01","url":null,"abstract":"In this case study, the author analyzed, predicted, and interpreted a type 2 diabetes (T2D) patient’s hemoglobin A1C variances based on six periods data utilizing the GH-Method: math-physical medicine approach by applying mathematics, physics, engineering modeling, and computer science (big data analytics and AI). He believes in “prediction” and has developed five models, including metabolism index, weight, fasting plasma glucose (FPG), postprandial plasma glucose (PPG), and hemoglobin A1C. All prediction models have reached to 95% to 99% accuracy. His focus is on preventive medicine, especially on diabetes control via lifestyle management.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"02 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86245108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Even though acupuncture and its reputed role in Traditional Chinese Medicine appears as a true value in East & West, from heart’s “perspective” it feels really as a false value. Acupuncture behaves as a stressor. Its way of approaching the skin, and especially the sensitive mechanoreceptors, fits more in challenging the nociceptors (pain receptors), rather than any other kind of basic skin receptors, such as haptic-stretch-pressure & vibration. This kindling mechanism, this external source of algorithmical conglomerative stress onto the skin, and consequently to other biological systems of the organism which are connected/entangled with it from the embryological phase of the three germ layers, has inevitably a direct link with the autonomic nervous system; the hypothalamic-pituitary-adrenal (HPA) axis with cortisol production, and the sympathoadrenal medullary (SAM) axis which activate the sympathetic nervous system, which dedicates energy to more relevant bodily systems to acute adaptation to stress. The above-mentioned neurobiological mechanisms are the basic major systems that respond to stress, and by extension they can affect through it (stress caused by acupuncture) the immune system.
{"title":"To Acu or not to Puncture?","authors":"","doi":"10.33140/jcei.05.04.05","DOIUrl":"https://doi.org/10.33140/jcei.05.04.05","url":null,"abstract":"Even though acupuncture and its reputed role in Traditional Chinese Medicine appears as a true value in East & West, from heart’s “perspective” it feels really as a false value. Acupuncture behaves as a stressor. Its way of approaching the skin, and especially the sensitive mechanoreceptors, fits more in challenging the nociceptors (pain receptors), rather than any other kind of basic skin receptors, such as haptic-stretch-pressure & vibration. This kindling mechanism, this external source of algorithmical conglomerative stress onto the skin, and consequently to other biological systems of the organism which are connected/entangled with it from the embryological phase of the three germ layers, has inevitably a direct link with the autonomic nervous system; the hypothalamic-pituitary-adrenal (HPA) axis with cortisol production, and the sympathoadrenal medullary (SAM) axis which activate the sympathetic nervous system, which dedicates energy to more relevant bodily systems to acute adaptation to stress. The above-mentioned neurobiological mechanisms are the basic major systems that respond to stress, and by extension they can affect through it (stress caused by acupuncture) the immune system.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89728426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The advantages of therapeutic apheresis (TA) with hollow fiber membranes are a complete separation of the corpuscular components from the plasma and due to increased blood flow rate higher efficacy [1]. The use of therapeutic apheresis in pediatric patients, which increasing more and more, has always been restricted by technical difficulties and the low incidence of diseases requiring this kind of treatment. The development of new, more sophisticated membranes and new adsorption technologies allow the most selective separation of plasma components. TA has been successfully introduced in a variety of autoantibody-mediated diseases [2]. The updated information on immunology and molecular biology of different neurological and hematological diseases are discussed in relation to the rationale for apheresis therapy and its place in combination with other modern treatments. The different diseases can be treated by various apheresis methods. Pathogenetical aspects are demonstrated in these diseases, in which they are clarified. TA has been shown to effectively remove the autoantibodies from blood and lead to rapid clinical improvement. For the neurological and hematological diseases, which can be treated with TA, the guidelines of the Apheresis Application Committee (AAC) of the American Society for Apheresis (ASFA) are cited [3, 4].
{"title":"Therapeutic Apheresis in Pediatrics with Neurological and Hematological Diseases","authors":"","doi":"10.33140/jcei.05.04.04","DOIUrl":"https://doi.org/10.33140/jcei.05.04.04","url":null,"abstract":"The advantages of therapeutic apheresis (TA) with hollow fiber membranes are a complete separation of the corpuscular components from the plasma and due to increased blood flow rate higher efficacy [1]. The use of therapeutic apheresis in pediatric patients, which increasing more and more, has always been restricted by technical difficulties and the low incidence of diseases requiring this kind of treatment. The development of new, more sophisticated membranes and new adsorption technologies allow the most selective separation of plasma components. TA has been successfully introduced in a variety of autoantibody-mediated diseases [2]. The updated information on immunology and molecular biology of different neurological and hematological diseases are discussed in relation to the rationale for apheresis therapy and its place in combination with other modern treatments. The different diseases can be treated by various apheresis methods. Pathogenetical aspects are demonstrated in these diseases, in which they are clarified. TA has been shown to effectively remove the autoantibodies from blood and lead to rapid clinical improvement. For the neurological and hematological diseases, which can be treated with TA, the guidelines of the Apheresis Application Committee (AAC) of the American Society for Apheresis (ASFA) are cited [3, 4].","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78449659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Since the Covid 19 broke out, people are all looking for the cure. Many people died from this fat al disease; and cytokine storm is one of the most dangerous complications. For some low-income people, they are not eligible to be tested for Covid; and they might not get the proper medical care. In these cases, self-care procedures, such as exercise, clear the airway, handwashing, wearing mask, taking meds on time, and proper diet become crucial in deciding the prognoses. This research is about a case study of a patient who is not eligible for a Covid 19 lab test; and how she dealt with a severe flu-like disease.
{"title":"Escaping Cytokine Storm for the Poor","authors":"","doi":"10.33140/jcei.05.04.03","DOIUrl":"https://doi.org/10.33140/jcei.05.04.03","url":null,"abstract":"Since the Covid 19 broke out, people are all looking for the cure. Many people died from this fat al disease; and cytokine storm is one of the most dangerous complications. For some low-income people, they are not eligible to be tested for Covid; and they might not get the proper medical care. In these cases, self-care procedures, such as exercise, clear the airway, handwashing, wearing mask, taking meds on time, and proper diet become crucial in deciding the prognoses. This research is about a case study of a patient who is not eligible for a Covid 19 lab test; and how she dealt with a severe flu-like disease.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86449812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This paper describes qualitatively and quantitatively the actions to protect some patients with chronic diseases and complications during this COVID-19 period.
本文定性和定量地介绍了在新冠肺炎疫情期间为保护部分慢性疾病及并发症患者采取的措施。
{"title":"Building up fundamental strength to fight against COVID-19 for patients with chronic diseases and complications","authors":"Gerald C. Hsu","doi":"10.33140/jcei.05.04.02","DOIUrl":"https://doi.org/10.33140/jcei.05.04.02","url":null,"abstract":"This paper describes qualitatively and quantitatively the actions to protect some patients with chronic diseases and complications during this COVID-19 period.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87874174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The objective of the study is to perform a critical review, exploration, and strong summary of the roles of mesenchymal stem cell transplantation in treating various diseases, including COVID-19. A comprehensive search was carried out in mainstream bibliographic databases or Medical Subject Headings, including Scien Direct, PubMed, Scopus, ISI Web of Science, and websites of the news. The search was applied to the articles that were published between January 2020 and April 2020. Needed article information was extracted from each article by : 1) direct information including journal (research article, review article, meeting abstract, conference abstract, correspondence, author index, editorial board meeting abstract, discussion), book chapter, title, authors, abstract, full text documents of candidate studies, websites of the news, publishing year; 2) study period; 3) research (study) method used; 4) types of mesenchymal stem cells; and 5) types of human organ system disorder or disease studied. With strict literature search and screening processes, it yielded 6 articles from 76 articles of initial literature databases and websites of the news (January 2020 to April 2020). Anti-inflammatory and immunomodulatory properties of MSCs in the treatment of respiratory diseases were confirmed by at least 17 clinical studies and more than 70 clinical trials are registered in this issue that are available at: https:// www.clinicaltrials.gov. MSC transplantation improves the treatment outcome of COVID-19 patients may be due to controlling inflammatory response and promoting tissue regeneration and repair. In conclusion, Human MSCs are currently being evaluated as a stem cell treatment for a number of diseases, particularly severe COVID-19 and have been demonstrated to be safe in clinical trials. There are some promising reports to apply MSCs therapy to treat COVID-19. MSCs may possibly be one of the most ideal therapeutics, or a combination of treatment to treat patients with COVID-19. Nevertheless, further studies are urgently needed to investigate and optimize a number of variables in the human MSC culture environment by developing a bioprocess that can be operated in accordance with the Good Manufacturing Product (GMP).
{"title":"Transplantation of Mesenchymal Stem Cells in Treating Patients with Severe\u0000COVID-19: A Systematic Review and Meta-Analysis","authors":"","doi":"10.33140/jcei.05.03.07","DOIUrl":"https://doi.org/10.33140/jcei.05.03.07","url":null,"abstract":"The objective of the study is to perform a critical review, exploration, and strong summary of the roles of mesenchymal\u0000stem cell transplantation in treating various diseases, including COVID-19. A comprehensive search was carried out\u0000in mainstream bibliographic databases or Medical Subject Headings, including Scien Direct, PubMed, Scopus, ISI Web\u0000of Science, and websites of the news. The search was applied to the articles that were published between January 2020\u0000and April 2020. Needed article information was extracted from each article by : 1) direct information including journal\u0000(research article, review article, meeting abstract, conference abstract, correspondence, author index, editorial board\u0000meeting abstract, discussion), book chapter, title, authors, abstract, full text documents of candidate studies, websites\u0000of the news, publishing year; 2) study period; 3) research (study) method used; 4) types of mesenchymal stem cells; and\u00005) types of human organ system disorder or disease studied. With strict literature search and screening processes, it\u0000yielded 6 articles from 76 articles of initial literature databases and websites of the news (January 2020 to April 2020).\u0000Anti-inflammatory and immunomodulatory properties of MSCs in the treatment of respiratory diseases were confirmed\u0000by at least 17 clinical studies and more than 70 clinical trials are registered in this issue that are available at: https://\u0000www.clinicaltrials.gov. MSC transplantation improves the treatment outcome of COVID-19 patients may be due to\u0000controlling inflammatory response and promoting tissue regeneration and repair. In conclusion, Human MSCs are\u0000currently being evaluated as a stem cell treatment for a number of diseases, particularly severe COVID-19 and have\u0000been demonstrated to be safe in clinical trials. There are some promising reports to apply MSCs therapy to treat\u0000COVID-19. MSCs may possibly be one of the most ideal therapeutics, or a combination of treatment to treat patients\u0000with COVID-19. Nevertheless, further studies are urgently needed to investigate and optimize a number of variables in\u0000the human MSC culture environment by developing a bioprocess that can be operated in accordance with the Good\u0000Manufacturing Product (GMP).","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87208184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In this paper, the author describes his methodology of developing an artificial intelligence (AI) based Glucometer to assist diabetes patients to control their glucose and HbA1C conditions.
{"title":"Controlling Type 2 Diabetes via Artificial Intelligence Technology (GH-Method:\u0000Math-Physical Medicine)","authors":"","doi":"10.33140/jcei.05.03.05","DOIUrl":"https://doi.org/10.33140/jcei.05.03.05","url":null,"abstract":"In this paper, the author describes his methodology of developing\u0000an artificial intelligence (AI) based Glucometer to assist diabetes\u0000patients to control their glucose and HbA1C conditions.","PeriodicalId":73657,"journal":{"name":"Journal of clinical & experimental immunology","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80127211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：